AGGRASTAT 5 mg/100mL (Tirofiban INJECTION, SOLUTION) 5 mg/100mL

AGGRASTAT (tirofiban) is an intravenous solution used to prevent blood clots. This medication is often utilized in cardiac procedures to maintain blood flow. AGGRASTAT 5 mg/100mL is designed for controlled administration.

Strength

5 mg/100mL

Pack Size

1 CONTAINER in 1 CARTON (25208-902-02) / 250 mL in 1 CONTAINER

Manufacturer / TM Owner

Medicure International Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AGGRASTAT is primarily used to prevent blood clots in patients undergoing certain cardiac procedures. It works by inhibiting platelet aggregation, which helps maintain blood flow. This medication is often administered during percutaneous coronary interventions (PCIs) to reduce the risk of ischemic complications. AGGRASTAT 5 mg/100mL is formulated for intravenous use, providing precise dosing for medical professionals.

Side Effects

AGGRASTAT may cause common effects such as bleeding, nausea, and headache. Some patients might experience dizziness or low blood pressure. These effects are generally mild and temporary, but severe reactions should be reported to a healthcare provider immediately.

Precautions & Warnings

AGGRASTAT should be handled with care, as it is intended for use in controlled medical settings. Patients with a history of bleeding disorders or recent surgery should use this medication under close supervision. Proper storage and administration techniques are essential to ensure safety and efficacy.

Avoid Interactions

AGGRASTAT may interact with other medications that affect blood clotting, such as anticoagulants and antiplatelet drugs. Alcohol and certain supplements can also influence its effects. It is important to consult a healthcare provider before combining AGGRASTAT with other treatments.

Frequently Asked Questions

AGGRASTAT is used to prevent blood clots in patients undergoing certain cardiac procedures, particularly percutaneous coronary interventions (PCIs).

AGGRASTAT is administered intravenously in a controlled medical setting. The solution is typically infused over a specified period to maintain therapeutic levels.

Common side effects of AGGRASTAT include bleeding, nausea, headache, dizziness, and low blood pressure. Severe reactions are rare but should be reported immediately.

AGGRASTAT may interact with other medications that affect blood clotting. It is important to consult a healthcare provider before combining it with other treatments.

AGGRASTAT should be used under medical supervision, especially in patients with a history of bleeding disorders or recent surgery. Proper storage and administration techniques are crucial.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.